Outcomes of the use of infliximab biosimilars in rheumatology and gastroenterology clinics.
Article in Journal of Managed Care & Specialty Pharmacy (January 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Biosimilars in the treatment of rheumatoid arthritis: a pharmacokinetic overview
Article in Expert Opinion on Drug Metabolism & Toxicology (October 2023)
Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis
Article in Scientific Reports (August 2023)